BioWorld - Friday, December 26, 2025 To read the full story, subscribe or sign in. Musculoskeletal Alebund Pharmaceuticals discovers new complement factor B inhibitors Dec. 2, 2025 Alebund Pharmaceuticals (Hong Kong) Ltd. has described complement factor B (CFB) inhibitors reported to be useful for the treatment of glomerular disorders and rheumatoid arthritis. BioWorld ScienceMusculoskeletalPatents